Meeting Videos

Implementing a National Cancer Clinical Trials System for the 21st Century: Workshop #2

Panel Discussion (15:57 )

Panel Discussion

  • Welcome John Mendelsohn
    Chair, National Cancer Policy Forum

    Welcome from the IOM’s National Cancer Policy Forum

  • Introduction Monica Bertagnolli
    Workshop Planning Committee Chair

    Introduction to Workshop

  • Workshop Wrap Up Monica Bertagnolli
    Workshop Planning Committee Chair

    Workshop Wrap Up

  • Panel Discussion Michael Caligiuri
    Ohio State University Comprehensive Cancer Center

    Panel Discussion

  • Wrapup of Day 1 Monica Bertagnolli
    Workshop Planning Committee Chair

    Wrapup of Day 1

Accelerating Innovation in Statistical Design
Lisa McShane
NCI Division of Cancer Treatment and Diagnosis

Accelerating Innovation in Statistical Design

An International Perspective from the UK Network on...
Richard Kaplan
UK National Cancer Research Network & Medical Research Council

An International Perspective from the UK Network on Prioritization of Trials

Challenges in Real World Implementation of Genomic...
Vincent Miller
Foundation Medicine

Challenges in Real World Implementation of Genomic Profiling for Eligibility in

Comprehensive Cancer Center Perspectives
Edward Benz
Dana-Farber Cancer Institute

Comprehensive Cancer Center Perspectives

EMA-FDA Harmonization
Francesco Pignatti
European Medicines Agency

EMA-FDA Harmonization

FDA Perspective on Data Quality Issues
Rachel Sherman
FDA Office of Medical Policy

FDA Perspective on Data Quality Issues

FDA/NCI collaboration – Independent Radiologic Review
Lori Dodd
NCI Biostatistics Research Branch

FDA/NCI collaboration – Independent Radiologic Review

Foundation Perspective
Margaret Anderson
FasterCures

Foundation Perspective

Funding clinical trials in the academic and community...
Marc Sabatine
Thrombolysis in Myocardial Infarction Study Group

Funding clinical trials in the academic and community research environment

IDE Requirements for Diagnostic Tests used in Clinical...
John Jessup
NCI Center for Cancer Research

IDE Requirements for Diagnostic Tests used in Clinical Trials

Industry Perspective
Renaud Capdeville
Novartis Oncology

Industry Perspective

Information from“Exceptional Responders”and the...
David Solit
Memorial Sloan-Kettering Cancer Center

Information from“Exceptional Responders”and the Implementation of Basket Trials

International Perspective: NEWDIGS Initiative, MIT Center...
Hans-Georg Eichler
European Medicines Agency

International Perspective: NEWDIGS Initiative, MIT Center for Biomedical Innovation

Introduction
Monica Bertagnolli
Workshop Planning Committee Chair

Introduction to Workshop

Introduction to Session 4
Barbara Conley
NCI Division of Cancer Treatment and Diagnosis

The NCTN as a Platform to Implement Precision Medicine

Metrics on the technical risks of cancer drug development & ...
Joseph DiMasi
Tufts Center for the Study of Drug Development

Metrics on the technical risks of cancer drug development & drug development times

NCI Updates
John Mendelsohn
Chair, National Cancer Policy Forum

NCI Updates

Optimizing Safety Data Collection in Cancer Clinical Trials
Richard L. Schilsky
ASCO

Optimizing Safety Data Collection in Cancer Clinical Trials

Panel Discussion
Michael Caligiuri
Ohio State University Comprehensive Cancer Center

Panel Discussion

Panel Discussion
Monica Bertagnolli
Alliance and DFCI

Panel Discussion

Panel Discussion
John Mendelsohn
Anderson Cancer Center

Panel Discussion

Panel Discussion
George Sledge
Stanford University School of Medicine

Panel Discussion

Panel Discussion
Richard L. Schilsky
American Society of Clinical Oncology

Panel Discussion

Panel Discussion
Barbara Conley
NCI Division of Cancer Treatment and Diagnosis

Panel Discussion

Panel Discussion
James Doroshow
NCI

Panel Discussion

Partnering with Advocates
Patrick Gavin
Patrick Gavin R.Ph. Consulting LLC

Partnering with Advocates

Pharmaceutical Industry
Sandra Horning
Genentech

Pharmaceutical Industry

Resources Needed for a Trial Employing Genomic Profiling...
Levi Garraway
Dana-Farber Cancer Institute

Resources Needed for a Trial Employing Genomic Profiling for Eligibility

Session 2 Introduction
John Mendelsohn
Anderson Cancer Center

Funding for Cancer Clinical Trials

Status report from the CTAC strategic planning subcommittee
Robert Diasio
Mayo Clinic Cancer Center

Status report from the CTAC strategic planning subcommittee

The Role of CTEP/NCI in Registration Trials
Jeffrey Abrams
NCI Division of Cancer Treatment and Diagnosis

The Role of CTEP/NCI in Registration Trials

Updates from the Cooperative Groups
Robert Comis
ECOG-ACRIN Cancer Research Group

Updates from the Cooperative Groups

Updates on CCOPs/NCCCP/NCORP
Worta McCaskill-Stevens
NCI Division of Cancer Prevention

Updates on CCOPs/NCCCP/NCORP

Welcome
John Mendelsohn
Chair, National Cancer Policy Forum

Welcome from the IOM’s National Cancer Policy Forum

Workshop Wrap Up
Monica Bertagnolli
Workshop Planning Committee Chair

Workshop Wrap Up

Wrapup of Day 1
Monica Bertagnolli
Workshop Planning Committee Chair

Wrapup of Day 1

Activity Staff

  • Sharyl Nass, Activity Director
  • View Full Activity Staff Roster

    • Erin Balogh

    • Cyndi Trang

    • Natalie Lubin

Activity Contact Information

For More Information Contact

Cyndi Trang
Phone:
202-334-2821
Fax:
202-334-2647
E-mail:
ctrang@nas.edu

Mailing Address


Keck Center
500 Fifth St. NW
Washington, DC 20001

Video Search